HSBC raises Eli Lilly price target to $940 from $850
Benzinga reports HSBC raised its Eli Lilly price target to $940.00 per share from $850.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.